drugset
drugset / Trial / NCT03907215

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects

NCT03907215 ↗

Phase 1 Completed 24 enrolled Idorsia Pharmaceuticals Ltd.
RandomizedCrossoverDouble-blindOther

Summary

A clinical study to examine the drug-drug interactions between ACT-541468 and citalopram in healthy male and female subjects

Timeline

Start
2019-04-09
Primary completion
2019-06-26
Completion
2019-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg Oral
Subject Daridorexant Small molecule 50 mg Oral

Indications

No indication recorded.